THE IBN SINA PHARMACEUTICAL INDUSTRY PLC

The IBN SINA Pharmaceutical Industry PLC

IBNSINA

BD0464IBNSN2

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
253.7 ^BDT	+0.28%		+0.04%	-11.48%

Feb. 01	The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022

September 06, 2022 at 11:03 am EDT

The Board of Directors of The IBN SINA Pharmaceutical Industry Ltd. has recommended 60% Cash Dividend for the year ended June 30, 2022.

Latest news about The IBN SINA Pharmaceutical Industry PLC

The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 15	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-30	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	23-08-29	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
The IBN SINA Pharmaceutical Industry Ltd. has Changed its Name to The IBN SINA Pharmaceutical Industry PLC	23-02-26	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-31	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-16	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Full Year Ended June 30, 2022	22-10-04	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	22-09-06	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-04-26	CI
The IBN SINA Pharmaceutical Industry Ltd. to Build Central Store at Gazipur	22-04-24	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-01-25	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-11	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021	21-10-27	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	21-09-22	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-04-29	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-01-26	CI
The IBN SINA Pharmaceutical Industry Ltd. Announces Decision to Form A Subsidiary Company	21-01-03	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2020	20-12-23	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended June 30, 2020	20-10-21	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Dividend for the Year Ended on June 30, 2020	20-09-19	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-04-30	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-26	CI
The IBN SINA Pharmaceutical Industry Ltd. to Establish Subsidiary Company	20-01-23	CI

Chart The IBN SINA Pharmaceutical Industry PLC

Duration

Period

Chart The IBN SINA Pharmaceutical Industry PLC

More charts

The IBN SINA Pharmaceutical Industry Ltd is a pharmaceutical company in Bangladesh. The Company is engaged in the production of pharmaceutical drugs and natural medicines. It sells its products to both local and international market. The Company offers its products in a range of therapeutic areas, such as anti-allergic occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, antifungal, anti-glucoma, anti-histamine, anti-malarial, anti-protozoal, antibiotic, antivertigo agent, antiviral, cough expectorant, dry eye syndrome, hormone products, nasal decongestant, topical, urinary incontinence and sterois-occular. The Company offers its products under various brand names, such as Aceril, Acipam, Algirex, Azopt, Antigrain, Bactin, Betasil, Buscon, Bromofen, Camide, Cardil, Cloram-D, Cinarzin, Dermacort, Dexon, Donadin, Emiston, Eylon, Fexomin, Fungin, Fruson, Gatsina, Glamor, Hexyclore, Iluca, Inseac, Ketof, Lansina, Lytex, Malex, Metsina, Natazol and Neuralgin.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for The IBN SINA Pharmaceutical Industry PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

253.7 BDT

Average target price

370 BDT

Spread / Average Target

+45.84%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
THE IBN SINA PHARMACEUTICAL INDUSTRY PLC	-11.48%	72.19M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals

The IBN SINA Pharmaceutical Industry PLC

Equities

IBNSINA

BD0464IBNSN2

Pharmaceuticals

The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022

Latest news about The IBN SINA Pharmaceutical Industry PLC

Chart The IBN SINA Pharmaceutical Industry PLC

Company Profile

Income Statement Evolution

Ratings for The IBN SINA Pharmaceutical Industry PLC

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals